UW20170
OPEN TO ACCRUAL
The Impact of DNA Repair Pathway Alt(s) Identified by ctDNA on Sensitivity to Rad223 in Bone mCRPC
UW21087
OPEN TO ACCRUAL
Phase 1/2 study of EPI-7386 in Combo with Enzalutamide vs. Enzalutamide Alone in mCRPC.
UW21088
OPEN TO ACCRUAL
Phase 1/2 Dose-Escalation and Cohort Expansion of ARV-766 for Metastatic Prostate Cancer
UW22158
OPEN TO ACCRUAL
P2 Study of Cabozantinib and Nivolumab in mCRPC (CANOPY)
UW24003
OPEN TO ACCRUAL
Clinical Validation of a Circulating Tumor Cell AR Therapy Resistance Assay in Men w/ mCRPC